| Trial ID: | L0600 |
| Source ID: | IRCT201407201155N21
|
| Associated Drug: |
Melatonin
|
| Title: |
Health impact of Melatonin, Metformin and Ursodeoxycholic acid in treatment of patients with Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease (NAFLD). <br>Nonalcoholic Fatty Liver Disease (NAFLD);K 76.0;Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Intervention 1: Intervention group 1:Melatonin,10 milligram, one number, daily. Intervention 2: Intervention group 2: Tab Metformin, 500 milligram one number, every 12 hours. Intervention 3: Intervention group 3: Cap Ursodeoxycholic acid, 300 milligram, o
|
| Outcome Measures: |
Serum levels of liver enzymes. Timepoint: initially and three months later. Method of measurement: Laboratory Kit.;Steatosis. Timepoint: initially and three months later. Method of measurement: using fibroscan.Serum Lipids. Timepoint: Initially and three months later. Method of measurement: Laboratory Kit.;Body Mass Index. Timepoint: Initially and three months later. Method of measurement: with Seca Scale.
|
| Sponsor/Collaborators: |
Vice chancellor for research of Guilan University of Medical Sciences
|
| Gender: |
All
|
| Age: |
no limitno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
120
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: The randomization in this study is Random Block.
|
| Start Date: |
22/09/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/245
|
